NEW YORK, NY / ACCESSWIRE / February 24, 2021 / Jakubowitz Law announces that securities fraud class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies who purchased shares within the class periods listed below. Shareholders interested in representing the class of wronged shareholders have until the lead plaintiff deadline to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. For more details and to speak with our firm without cost or obligation, follow the links below.
SolarWinds Corporation (NYSE:SWI)
CONTACT JAKUBOWITZ ABOUT SWI:
https://claimyourloss.com/securities/solarwinds-corporation-loss-submission-form/?id=13111&from=1
Class Period : October 18, 2018 - December 17, 2020
Lead Plaintiff Deadline : March 5, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) since mid-2020, SolarWinds Orion monitoring products had a vulnerability that allowed hackers to compromise the server upon which the products ran; (2) SolarWinds' update server had an easily accessible password of ‘solarwinds123'; (3) consequently, SolarWinds' customers, including, among others, the Federal Government, Microsoft, Cisco, and Nvidia, would be vulnerable to hacks; (4) as a result, the Company would suffer significant reputational harm; and (5) as a result, Defendants' statements about SolarWinds's business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Tricida, Inc. (NASDAQ:TCDA)
CONTACT JAKUBOWITZ ABOUT TCDA:
https://claimyourloss.com/securities/tricida-inc-loss-submission-form/?id=13111&from=1
Class Period : September 4, 2019 - October 28, 2020
Lead Plaintiff Deadline : March 8, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Tricida's NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Cleanspark, Inc. (NASDAQ:CLSK)
CONTACT JAKUBOWITZ ABOUT CLSK:
https://claimyourloss.com/securities/cleanspark-inc-loss-submission-form/?id=13111&from=1
Class Period : December 31, 2020 - January 14, 2021
Lead Plaintiff Deadline : March 22, 2021
The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) that the Company had overstated its customer and contract figures; (2) that several of the Company's recent acquisitions involved undisclosed related party transactions; and (3) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
JAKUBOWITZ LAW
1140 Avenue of the Americas
9th Floor
New York, New York 10036
T: (212) 867-4490
F: (212) 537-5887
SOURCE: Jakubowitz Law